| Ytd | 75.78% | |
| 1y | 69.87% |
| Open | 2.00 | Prev Close | 2.05 | Low | 2.00 | High | 2.08 | Mkt Cap | 898.81M |
| Vol | 126.24K | Avg Vol | 3.43M | EPS | -0.16 | P/E | N/A | Forward P/E | -11.86 |
| Beta | 1.02 | Short Ratio | 11.53 | Inst. Own | 83.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 2.27 | 200-d Avg | 1.82 | 1yr Est | 3.86 |
LXRX News
Lexicon Pharmaceuticals (NASDAQ: LXRX) said it has completed enrollment in its Phase III SONATA-HCM
Lexicon Pharmaceuticals NASDAQ: LXRX said it has completed enrollment in its Phase III SONATA-HCM st
U.S. stock futures rose, but Beta Bionics fell 7.1% after pricing a stock offering; several other st
Tempest shares surged 49.6% on a Senlang CD7 CAR-T option deal, while several small-cap stocks poste
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.07) per share which missed th
The study substantially exceeded its enrollment target of 500 patients across more than 130 sites in
Citigroup analyst Yigal Nochomovitz maintains Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy an
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly sales of $1.090 million which missed the an
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that results from its PROGRESS Phase 2b
U.S. stock futures up, Dow gains 150 points. Avis Budget Group (CAR) shares fall 9.6% in pre-market.
HC Wainwright & Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX)
In March 2025, Lexicon signed an exclusive license agreement with Novo Nordisk for LX9851 in obesity
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that results of a post hoc analysis of
HC Wainwright & Co. analyst Joseph Pantginis maintains Lexicon Pharmaceuticals (NASDAQ:LXRX)
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Mo
U.S. stock futures fell on Monday after three consecutive days of decline on Friday. Futures of benc
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monda
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company a
U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter resu
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its
Gainers